Connect with us


Amid vaccine spat, Maharashtra tops with 93L jabs



COVID-19 Vaccine. (Photo: IANS)

Amid a major ‘vaccine-war’ with the Centre, it has emerged that Maharashtra continues to fly high in terms of the inoculation drive despite having nearly-exhausted its stocks, officials said here on Friday.

As per the latest data released for April 9 (today), the state has administered the highest 93,38,531 jabs, comprising 84,35,010 first doses and 903,521 second doses, making it the best performer in the national vaccination programme, officials pointed out.

The state is followed by Rajasthan with 88,07,351 vaccinations comprising 77,72,197 first jabs and 10,35,194 second doses.

Next is Gujarat with 84,75,305 vaccinations including 75,01,404 first doses and 973,901 second jabs.

In the past two days, the Centre and Maharashtra have been engaged in a bitter war of words with the latter accusing the former of ‘stepmotherly treatment’ for the state which is worst-hit by the Covid-19 pandemic.

Top leaders of the Maha Vikas Aghadi government and Shiv Sena-Nationalist Congress Party-Congress said that the Centre has not given sufficient numbers of vaccines to Maharashtra but was allegedly concentrating on Gujarat and other states ruled by Bharatiya Janata Party.

Lashing out at the MVA, BJP’s Leader of Opposition Fadnavis said on Thursday evening that the vaccines’ “supply is not on the basis of population but purely based on state’s performance of execution of vaccination process”.

Refuting the MVA leaders’ contentions, Fadnavis also pointed out that only three states — Maharashtra, Gujarat and Rajasthan — have been given over 1-crore doses by the Centre.

While Maharashtra has a population of 12 crore, Gujarat and Rajasthan each have around 6 crore population, and the latter is ruled by Congress, he said.

As per the current figures, Uttar Pradesh ranks fourth with 81,45,161 vaccinations notched till date, comprising 69,51,956 first jabs and 11,93,205 second doses.

At the bottom of the list are less-populated smaller territories like Lakshadweep Islands (10,737), Union Territory of Daman & Diu (28,441), Andaman & Nicobar Islands (30,799), and Union Territory of Dadra & Nagar Haveli (31,851).


Bombay High Court slams DMs for modifying its direction on Covid negative certificate




The Bombay High Court bench in Goa on Tuesday slammed the district administration for modifying its order on making Covid negative certificates mandatory for persons entering the state.

The HC order comes a day after the state’s two District Magistrates issued an order making it mandatory for tourists only to carry Covid negative certificates, even as the HC last week had directed them to make Covid negative certificates to everyone entering the state.

A statement issued by the South Goa Advocates Association, one of the primary petitioners, said that the Advocate General of Goa Devidas Pangam had assured the Court that the administrative orders would be modified and would be “consistent with the orders of the HC”.

“In respect to the supply and availability of oxygen, the High court has directed the Dean of Goa Medical College, Director of Health Services and Goa Association of Resident Doctors to file an affidavit on the issue of supply and Aavailability of oxygen at Goa Medical College, North Goa District Hospital, South Goa District Hospital and Employees’ State Insurance hospital,” the statement said.

The Goa government has also been directed to file an affidavit on other aspects of Covid management including availability of “ambulances, hearse vans, increase in number of beds, ICU beds, ventilator,” the statement said.

Continue Reading


ED books ex-Maharashtra Home Minister Anil Deshmukh under PMLA




The Enforcement Directorate (ED) has registered a case of money laundering against former Maharashtra Home Minister and Nationalist Congress Party (NCP) leader Anil Deshmukh in connection with alleged corruption and misuse of office case.

A senior ED official related to probe told IANS, “A case of money laundering has been registered under PMLA against Deshmukh.”

The ED action comes almost a fortnight after the CBI booked the NCP leader into the allegations of misuse of office and corruption on April 24.

The CBI registered a preliminary enquiry on April 6 after the Bombay High Court asked the agency to probe the allegations of bribery and misuse of office.

Soon after the ruling, Deshmukh stepped down from his post.

The CBI has carried out searches at premises linked to Deshmukh and also recorded his statement earlier.

Continue Reading


Maharashtra scientist’s ‘stem-cell’ remedy kills Covid naturally



Concerned over the massive COVID-19 surge in the country, a Maharashtra researcher-cum-scientist has developed a unique stem-cell/platelet-based remedy to kill the Coronavirus “naturally, with anti-inflammatory bodies” and reduce the need for hospitalization of COVID patients by 65-75 per cent.

Navi Mumbai-based Urologist-cum-regenerative medicine researcher Dr Pradeep V. Mahajan, 61, said that the stem-cell/lyophilised platelet remedy is a proven protocol for COVID and post-COVID patients on OPD basis, without requiring hospitalization for targeting the primary lung disease.

Dr Mahajan – Chairman of StemRx Biosciences Solutions Pvt Ltd – said that the lungs are the prime target of Covid, causing maximum morbidity, highest stay in ICU/ventilators and deaths, and post-treatment, the patient requires oxygen for several months as lungs develop fibrosis.

“Most drugs, medicines, various forms of treatment and even vaccines fail to give the desired success rate as they are targeting the virus, not its environment. So, to survive, it keeps mutating, and we fumble for newer remedies. My protocol is simple – I tackle and strengthen the environment which kills the Coronavirus naturally,” Dr Mahajan pointed out.

Elaborating, he said for this, his team acquires blood platelets – considered the first line defence of the lungs, followed by white blood corpuscles and platelets for the next stage of the healing process.

“We take the platelets from regular blood banks or donors, they are lysed, (to remove its walls to extract the granules), convert them into a powder and administer as a mixture through a Nebuliser or a Rotahaler directly into the lungs – similar to any asthma patients,” Dr Mahajan said.

These pumps (Nebuliser-Rotahaler) are easily available for between Rs 250-Rs 1,500 apiece, while the stem-cell concoction used in them is prepared in a special lab machine.

Presently, Dr Mahajan has installed one such small capacity machine at the StemRx facility, Seven Hills Hospital in Andheri, Mumbai.

“At current costs, a patient would have to pay around Rs 600-700 per vial, needs 14 vials for a week, and then 1 vial daily for 3/4 weeks for recovery from post-Covid morbid conditions like lung fibrosis. Patients can be treated at home during quarantine, with our fleet of ambulances to help administer the solution to them, and eliminating the stage for oxygen beds or ventilators,” Dr Mahajan smiled.

In the early phase of the disease, he claimed that the stem-cell/lyophilised platelet remedy works like a miracle, reduces hospitalization needs by over 50 per cent, axes a massive load off the government-private health network, besides preventing mutations of the virus and slashing post-Covid complications, as are being witnessed now.

Dr Mahajan’s machine (Freeze Drier/Lyophilizer) – costing around Rs One crore – produces 3,000 vials daily though bigger machines can boost production enhancement to cater to major cities like Mumbai, Delhi, Bengaluru, Thiruvananthapuram, Chandigarh, Ahmedabad, etc, within a fortnight.

“I have approached the Maharashtra Government, the Union Health Ministry and other states to help us set up similar facilities nationwide, or at least in all districts where Covid is taking a huge toll. We can overpower the virus by the year-end at a fraction of the costs now being spent per patient by the government,” Dr Mahajan declared.

He added that stem-cell therapy/lyophilised platelet nebulisation would work complementary to other treatment protocols, at least till it can be produced on a mass-scale to make it available in every neighbourhood family doctor’s clinic to be prescribed as ‘home-treatment’.

The scientist is also exploring possibilities of local corporates or Members of Parliament funding one such Machine for his/her constituency out of the MPLADS to cater to the local population and prevent overloading medicare facililties.

Continue Reading